Expert Perspective on Real-World Follow-Up Analyses of Liso-Cel in LBCL
February 13th 2024
Caron A. Jacobson, MD, and Miguel-Angel Perales, MD, review the impact of real-world analysis and how they may shape guidelines and clinical approaches with respect to the use of CAR T-cell therapy in LBCL.In particular, they note how continued research bolsters the safety profile of these agents.